在骨髓纤维化中,通过全源性造血干细胞移植重建骨平衡
Mathias Schäfersküpper1, Alexander Simon2,3, Timur A Yorgan2
1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Nature communications
|January 20, 2025
概括
全基性造血干细胞移植 (allo-HSCT) 逆转了骨髓纤维化和骨质硬化在骨髓纤维化患者. 这种疗法恢复了骨平衡和平衡,改善了患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 骨生物学 骨生物学
背景情况:
- 骨髓纤维化是一种骨髓扩散性瘤,会导致骨髓纤维化,外骨髓造血和大.
- 全基性造血干细胞移植 (allo-HSCT) 是髓纤维化病的唯一治愈治疗方法,导致纤维化回归.
研究的目的:
- 在alo-HSCT之前和之后对髓纤维化患者的骨变化进行全面的描述.
- 为了研究-HSCT对骨矿物密度,微型结构和骨髓纤维化中的骨重塑的影响.
主要方法:
- 临床高分辨率成像 (例如DXA扫描).
- 对骨代谢标记物的实验室分析.
- 骨活检研究用于组织学评估.
- 在alo-HSCT前后对患者进行纵向监测.
主要成果:
- 骨髓纤维化患者在腰椎和靠近大腿骨的骨矿物质密度增加,这与纤维化和骨硬化有关.
- 周围骨微型架构在很大程度上没有受到损害.
- 阿洛-HSCT导致骨矿物质密度的完全正常化,骨质硬化症的回归和骨质硬化活动的恢复.
- 骨平衡和全身平衡在移植后得到恢复.
结论:
- 在骨髓纤维化患者中,Allo-HSCT有效地重建了骨平衡.
- 治疗诱导骨质硬化和纤维化的快速解决,与骨代谢的正常化一起.
- 这项研究突出了骨的深刻影响和治疗治疗肌肉纤维化后的恢复.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


